[ Price : $8.95]
FDA lifts a clinical hold on Alnylam Pharmaceuticals clinical studies with fitusiran, indicated for treating patients with hemophi...[ Price : $8.95]
Federal Register notice: FDA makes available a draft guidance entitled The Least Burdensome Provisions: Concept and Principles tha...[ Price : $8.95]
Federal Register notice: FDA issues a priority review voucher to Ultragenyx Pharmaceutical for obtaining approval of a rare pediat...[ Price : $8.95]
Federal Register correction notice: FDA corrects an 11/27 notice entitled Safety Assessment for Investigational New Drug Safety Re...[ Price : $8.95]
Citing correspondence addressed to then-new commissioner Scott Gottlieb, the Project On Government Oversight questions how biotech...[ Price : $8.95]
Medtronic agrees to a $12 million settlement with five states over alleged deceptive promotion of its Infuse bone graft system.[ Price : $8.95]
FDA publishes a draft guidance explaining its view of Congress requirement that it apply least burdensome principles to medical de...[ Price : $8.95]
FDA scientists say it is possible to standardize high throughput sequencing to screen biologics for contamination.